With Zika virus raising concerns around the United States about the spread of mosquito-borne diseases, the transmission of these viruses has become paramount in terms of how, when and where they are spread. Researchers at ...
Oct 7, 2016
0
3
A research team spanning four continents has detailed the anti-viral capabilities of OSU-03012, also known as AR-12, a drug currently used in clinical trials to treat certain cancer tumors. The present study confirms that ...
Jul 5, 2016
0
96
Researchers at Albert Einstein College of Medicine and the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) have engineered the first antibodies that can potently neutralize the two deadliest strains ...
Jan 13, 2016
0
844
The Ebola virus acts fast. The course of infection, from exposure to recovery, or death, can take as little as two weeks. That may not leave enough time for the immune system to mount an effective response.
Oct 30, 2015
0
110
Scientists at the University of California, Berkeley, have identified a key culprit responsible for the fluid loss and resulting shock that are the hallmark of severe - and potentially fatal - dengue virus infections.
Sep 9, 2015
0
113
Clinical trials for a dengue fever treatment could start within a year, following a discovery by University of Queensland scientists.
Sep 9, 2015
0
13
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola. The findings were recently published ...
Jul 13, 2015
0
124
Researchers at Vanderbilt University and the National University of Singapore have determined the structure of a human monoclonal antibody which, in an animal model, strongly neutralizes a type of the potentially lethal dengue ...
Jul 2, 2015
0
70
Brain tumors are notoriously difficult for most drugs to reach, but Yale researchers have found a promising but unlikely new ally against brain cancers—portions of a deadly virus similar to Ebola.
Apr 17, 2015
0
50
(Medical Xpress)—A team of researchers working in Singapore has found that human T cells actually target dengue viral infections in the skin, which is the normal infection site. In their paper published in the journal Science ...
